Kalytera Announces Formation of Strategic and Scientific Advisory Board to Assist with Development of Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain Biotech Investing
PreveCeutical Medical: Second Shipment of Dried Cannabis Materials Arrives at the Pharmacy Australia Centre of Excellence Biotech Investing
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies Pharmaceutical Investing
Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation Cannabis Investing News
